MDI VS CSII IN PREGNANCY WITH TYPE1 DIABETES

被引：0
|
作者：
Torlone, E.
机构：
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
035
引用
收藏
页码：A12 / A13
页数：2
相关论文
共 50 条
  • [21] CSII vs MDI therapy in childhood and adolescent diabetes: the results of 3 years follow-up
    Emelyanov, Andrey O.
    Kuraeva, Tamara L.
    Peterkova, Valentina A.
    HORMONE RESEARCH, 2009, 72 : 186 - 186
  • [22] Fear of Hypoglycemia in Relatives of Young Type 1 Diabetes Mellitus (T1DM) Patients on MDI and CSII Therapy
    Patrakeeva, Evgenya M.
    Zalevskaya, Alsu G.
    Shlyakhto, Evgeniy V.
    DIABETES, 2014, 63 : A212 - A212
  • [23] SIX MONTHS CSII TREATMENT IMPROVES ARTERIAL STIFFNESS AND ENDOTHELIAL GLYCOCALYX VS MDI INTENSIFICATION IN PATIENTS WITH TYPE 1 DIABETES INDEPENDENTLY OF GLYCEMIC CONTROL.
    Kountouri, A.
    Thymis, J.
    Kousathana, F.
    Balampanis, K.
    Pliouta, L.
    Prentza, V.
    Katogiannis, K.
    Kostelli, G.
    Barmpagianni, A.
    Liatis, S.
    Ikonomidis, I.
    Lambadiari, V.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A153 - A153
  • [24] Level of glycemic control and pregnancy outcome in type-1 diabetes: A comparison between multiple daily injections (MDI) and continuous subcutaneous insulin infusions (CSII)
    Chen, Rony
    Yogev, Yariv
    Weissman-Brenner, Alina
    Haroush, Avi Ben
    Hod, Moshe
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (06) : S132 - S132
  • [25] Level of glycemic control and pregnancy outcome in type-1 diabetes: A comparison between multiple daily injections (MDI) and continuous subcutaneous insulin infusions (CSII)
    Chen, Rony
    Yogev, Yariv
    Weissman-Brenner, Alina
    Ben-Haroush, Avi
    Hod, Moshe
    DIABETES, 2007, 56 : A703 - A703
  • [26] Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)
    Kumar, RP
    Hirsch, IB
    DIABETES, 2004, 53 : A110 - A110
  • [27] THE PUMP TREATMENT (CSII) IN TYPE 2 DIABETES COMPARED TO INTENSIFIED INSULIN ANALOG (MDI) TREATMENT
    Gruberova, J.
    Jankovec, Z.
    Lacigova, S.
    Tomesova, J.
    Rusavy, Z.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A40 - A41
  • [28] Effect of the Omnipod® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII
    Mehta, Sanjeev N.
    Kruger, Davida F.
    Bode, Bruce W.
    Layne, Jennifer E.
    Dumais, Bonnie
    Gallagher, Jack R.
    Ly, Trang T.
    DIABETES, 2019, 68
  • [29] FALLS AND FRACTURES IN PATIENTS WITH TYPE1 DIABETES
    Sulaiman, Raashda A.
    Narendran, Parth
    Cooper, Mark
    Ayuk, John
    Hiwot, Tarekegn
    Gittoes, Neil
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S599 - S599
  • [30] EATING DISORDERS IN SUBJECTS WITH T1DM: COMPARISON BETWEEN MDI VS CSII
    Rizzi, A.
    Policola, C.
    Tartaglione, L.
    Foca, F.
    Chieffo, D.
    Leo, L.
    Della Casa, S.
    Di Leo, M.
    Pitocco, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A264 - A265
12345